Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CyberHeart developed a non‑invasive stereotactic radiosurgery system that uses treatment‑planning software with CT‑based 3D heart models and robotic radiosurgery (e.g., CyberKnife) to ablate cardiac arrhythmogenic tissue and renal nerves; early first‑in‑human and preclinical studies in atrial fibrillation, ventricular tachycardia and renal denervation have shown technical feasibility, lesion formation and promising safety over up to 24 months, but the technology has not yet received FDA approval for cardiac radioablation.[1][2][3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CyberHeart.